229 related articles for article (PubMed ID: 17334350)
1. Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.
Rodriguez-Pinilla SM; Sarrio D; Moreno-Bueno G; Rodriguez-Gil Y; Martinez MA; Hernandez L; Hardisson D; Reis-Filho JS; Palacios J
Mod Pathol; 2007 Apr; 20(4):474-81. PubMed ID: 17334350
[TBL] [Abstract][Full Text] [Related]
2. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.
Rodríguez-Pinilla SM; Sarrió D; Honrado E; Moreno-Bueno G; Hardisson D; Calero F; Benítez J; Palacios J
J Clin Pathol; 2007 Sep; 60(9):1006-12. PubMed ID: 17105822
[TBL] [Abstract][Full Text] [Related]
3. Metaplastic breast carcinomas are basal-like tumours.
Reis-Filho JS; Milanezi F; Steele D; Savage K; Simpson PT; Nesland JM; Pereira EM; Lakhani SR; Schmitt FC
Histopathology; 2006 Jul; 49(1):10-21. PubMed ID: 16842242
[TBL] [Abstract][Full Text] [Related]
4. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
[TBL] [Abstract][Full Text] [Related]
5. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].
Liu H; Fan QH; Zhang ZH; Li X; Yu HP; Liu GZ; Meng FQ
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):23-8. PubMed ID: 19489221
[TBL] [Abstract][Full Text] [Related]
6. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.
Rodríguez-Pinilla SM; Sarrió D; Honrado E; Hardisson D; Calero F; Benitez J; Palacios J
Clin Cancer Res; 2006 Mar; 12(5):1533-9. PubMed ID: 16533778
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.
Marotti JD; Collins LC; Hu R; Tamimi RM
Mod Pathol; 2010 Feb; 23(2):197-204. PubMed ID: 19898422
[TBL] [Abstract][Full Text] [Related]
9. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
Rodríguez-Pinilla SM; Rodríguez-Gil Y; Moreno-Bueno G; Sarrió D; Martín-Guijarro Mdel C; Hernandez L; Palacios J
Am J Surg Pathol; 2007 Apr; 31(4):501-8. PubMed ID: 17414096
[TBL] [Abstract][Full Text] [Related]
10. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.
Bhargava R; Beriwal S; Striebel JM; Dabbs DJ
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):113-8. PubMed ID: 19801938
[TBL] [Abstract][Full Text] [Related]
12. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
Collins LC; Martyniak A; Kandel MJ; Stadler ZK; Masciari S; Miron A; Richardson AL; Schnitt SJ; Garber JE
Am J Surg Pathol; 2009 Jul; 33(7):1093-7. PubMed ID: 19390427
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtyping of male breast cancer by immunohistochemistry.
Kornegoor R; Verschuur-Maes AH; Buerger H; Hogenes MC; de Bruin PC; Oudejans JJ; van der Groep P; Hinrichs B; van Diest PJ
Mod Pathol; 2012 Mar; 25(3):398-404. PubMed ID: 22056953
[TBL] [Abstract][Full Text] [Related]
14. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.
Castilla MÁ; López-García MÁ; Atienza MR; Rosa-Rosa JM; Díaz-Martín J; Pecero ML; Vieites B; Romero-Pérez L; Benítez J; Calcabrini A; Palacios J
Endocr Relat Cancer; 2014 Aug; 21(4):587-99. PubMed ID: 24891455
[TBL] [Abstract][Full Text] [Related]
15. Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas.
Fernandes RC; Bevilacqua JL; Soares IC; Siqueira SA; Pires L; Hegg R; Carvalho FM
Histopathology; 2009 Sep; 55(3):346-52. PubMed ID: 19723150
[TBL] [Abstract][Full Text] [Related]
16. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study.
Sousa B; Paredes J; Milanezi F; Lopes N; Martins D; Dufloth R; Vieira D; Albergaria A; Veronese L; Carneiro V; Carvalho S; Costa JL; Zeferino L; Schmitt F
Histol Histopathol; 2010 Aug; 25(8):963-74. PubMed ID: 20552547
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
Reyes C; Jorda M; Gomez-Fernández C
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
[TBL] [Abstract][Full Text] [Related]
18. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.
Pinilla SM; Honrado E; Hardisson D; Benítez J; Palacios J
Breast Cancer Res Treat; 2006 Sep; 99(1):85-90. PubMed ID: 16541313
[TBL] [Abstract][Full Text] [Related]
20. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER
Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ
J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
